17 Apr 2013, BioSpectrum Bureau , BioSpectrum
Singapore: Seegene, a leading developer of multiplexed molecular technologies and diagnostic tests, has given bioMérieux license to the company's DPO and TOCE technologies for the development of multiplexed tests for food safety testing. Financial terms of the agreement were not disclosed.
The increased prevalence of foodborne illnesses is driving regulators and the food industry to advance food safety testing from pathogens to virulence genes detection.
Dr Jong-Yoon Chun, founder, CTO and CEO, Seegene, said that, "We are excited to collaborate with bioMérieux, the leading player in the food testing market, to develop the next generation of high-value, multiplexed molecular diagnostic food safety tests. We believe that the adoption of our leading multiplexing technology will curtail future food contamination outbreaks, save lives and help to grow this important market."